In line with this, PARP inhibition with L-2286 preserved systolic LV function and attenuated cardiac hypertrophy and interstitial fibrosis in ISO-induced chronic heart failure in rats [42]. This evidence concerns the gene PARP1 and cardiac hypertrophy.